Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma

Clinical trial NCT02945800 · COMPLETED

Trial details

NCT number: NCT02945800
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Osteosarcoma Ewing Sarcoma Rhabdomyosarcoma Soft Tissue Sarcoma

Start date: 2016-10-25
Primary completion: 2024-11-19
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.